SCHEMBL268792

SCHEMBL268792

Cc1cnc(C)o1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL27345029 0.97
SCHEMBL5156652 0.77
SCHEMBL15070886 0.73
SCHEMBL5154398 0.71
SCHEMBL13453313 0.71
SCHEMBL5537140 0.71
SCHEMBL1691403 0.71
SCHEMBL21653365 0.71
SCHEMBL19623761 0.71
SCHEMBL17213366 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1244 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240002359-A1 3-HETEROARYL PYRROLIDINE AND PIPERIDINE OREXIN RECEPTOR AGONISTS MERCK SHARP & DOHME LLC (US) 2024-01-04 US claimed
EP-4255429-A1 3-HETEROARYL PYRROLIDINE AND PIPERIDINE OREXIN RECEPTOR AGONISTS Merck Sharp & Dohme LLC (US) 2023-10-11 EP claimed
WO-2022119888-A1 3-HETEROARYL PYRROLIDINE AND PIPERIDINE OREXIN RECEPTOR AGONISTS MERCK SHARP & DOHME CORP. (US) 2022-06-09 WO claimed
CN-111518779-B Oxazole cyclase gene and coding protein and application thereof 沈阳药科大学 2022-03-11 CN claimed
CN-111518779-A Oxazole cyclase gene and coding protein and application thereof 沈阳药科大学 2020-08-11 CN claimed
US-12404295-B2 (Hetero)aryl-methyl-thio-beta-D-galactopyranoside derivatives IDORSIA PHARMACEUTICALS LTD (CH) 2025-09-02 US disclosed
US-20250122402-A1 LONG SHELF-LIFE STABLE MASS POLYMERIZABLE POLYCYCLOOLEFIN COMPOSITIONS CONTAINING PYRIDINE LIGATED PALLADIUM COMPOUNDS PROMERUS, LLC (US) 2025-04-17 US disclosed
US-20240307382-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ABBVIE INC. 2024-09-19 US disclosed
US-12043623-B2 Purinones as ubiquitin-specific protease 1 inhibitors FORMA THERAPEUTICS, INC. (US) 2024-07-23 US disclosed
US-20240239780-A1 MODIFIED FERROPORTIN INHIBITORS VIFOR (INTERNATIONAL) AG (CH) 2024-07-18 US disclosed
WO-2024141757-A1 LSD1 MODULATORS EXSCIENTIA AI LIMITED (GB) 2024-07-04 WO disclosed
US-12023319-B2 Carboxylic acid aromatic amides BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2024-07-02 US disclosed
EP-0107599-A1 Process for the preparation of saturated linear esters by carbonylation of monoolefinic compounds RHONE-POULENC CHIMIE DE BASE (FR) 1984-05-02 EP disclosed
EP-0087953-A2 Antibacterial 1-normon-2-yl-heterocyclic compounds BEECHAM GROUP PLC (GB) 1983-09-07 EP disclosed
EP-0003329-B1 CEPHALEXIN-AMIDE COMPLEX, PROCESS FOR ITS PRODUCTION AND USE IN CEPHALEXIN-MONOHYDRATE PRODUCTION BIOCHEMIE Gesellschaft m.b.H. (AT) 1981-09-23 EP disclosed
EP-0034924-A2 Process for preparing 3-iodomethyl cephalosporins ELI LILLY AND COMPANY (US) 1981-09-02 EP disclosed
US-4266049-A Process for 3-iodomethyl cephalosporins ELI LILLY AND COMPANY (US) 1981-05-05 US disclosed
US-4261818-A Method for making separations from aqueous solutions SWEENEY MAXWELL P 1981-04-14 US disclosed
EP-0003329-A1 Cephalexin-amide complex, process for its production and use in cephalexin-monohydrate production BIOCHEMIE Gesellschaft m.b.H. (AT) 1979-08-08 EP disclosed
US-3941836-A SOLUBILIZERS, PLASTICIZER, UV ABSORBER THE LUBRIZOL CORPORATION (US) 1976-03-02 US disclosed